Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 20547735)

1.

Regulation of ABC transporters at the blood-brain barrier.

Miller DS.

Clin Pharmacol Ther. 2015 Apr;97(4):395-403. doi: 10.1002/cpt.64. Epub 2015 Jan 20. Review.

PMID:
25670036
2.

Drug delivery systems, CNS protection, and the blood brain barrier.

Upadhyay RK.

Biomed Res Int. 2014;2014:869269. doi: 10.1155/2014/869269. Epub 2014 Jul 20. Review.

3.

Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.

Wang X, Campos CR, Peart JC, Smith LK, Boni JL, Cannon RE, Miller DS.

J Neurosci. 2014 Jun 18;34(25):8585-93. doi: 10.1523/JNEUROSCI.2935-13.2014.

4.

A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources.

Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV.

Sci Rep. 2014 Feb 24;4:4160. doi: 10.1038/srep04160.

5.

Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.

Slosky LM, Thompson BJ, Sanchez-Covarrubias L, Zhang Y, Laracuente ML, Vanderah TW, Ronaldson PT, Davis TP.

Mol Pharmacol. 2013 Nov;84(5):774-86. doi: 10.1124/mol.113.086298. Epub 2013 Sep 9.

6.

The blood-brain barrier: an engineering perspective.

Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE, Searson PC.

Front Neuroeng. 2013 Aug 30;6:7. doi: 10.3389/fneng.2013.00007. Review.

7.

Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains.

Ghosh C, Hossain M, Puvenna V, Martinez-Gonzalez J, Alexopolous A, Janigro D, Marchi N.

Epilepsia. 2013 Sep;54(9):1562-70. doi: 10.1111/epi.12318. Epub 2013 Jul 19.

8.

Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells.

Chan GN, Patel R, Cummins CL, Bendayan R.

Antimicrob Agents Chemother. 2013 Sep;57(9):4481-8. doi: 10.1128/AAC.00486-13. Epub 2013 Jul 8.

9.

Targeted drug delivery to treat pain and cerebral hypoxia.

Ronaldson PT, Davis TP.

Pharmacol Rev. 2013 Jan 23;65(1):291-314. doi: 10.1124/pr.112.005991. Print 2013 Jan. Review.

10.

Functional regulation of P-glycoprotein at the blood-brain barrier in proton-coupled folate transporter (PCFT) mutant mice.

Wang X, Cabrera RM, Li Y, Miller DS, Finnell RH.

FASEB J. 2013 Mar;27(3):1167-75. doi: 10.1096/fj.12-218495. Epub 2012 Dec 4.

11.

1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.

Durk MR, Chan GN, Campos CR, Peart JC, Chow EC, Lee E, Cannon RE, Bendayan R, Miller DS, Pang KS.

J Neurochem. 2012 Dec;123(6):944-53. doi: 10.1111/jnc.12041. Epub 2012 Nov 1.

12.

Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Cannon RE, Peart JC, Hawkins BT, Campos CR, Miller DS.

Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15930-5. Epub 2012 Sep 4.

13.

Compartment-specific gene regulation of the CAR inducer efavirenz in vivo.

Meyer zu Schwabedissen HE, Oswald S, Bresser C, Nassif A, Modess C, Desta Z, Ogburn ET, Marinova M, Lütjohann D, Spielhagen C, Nauck M, Kroemer HK, Siegmund W.

Clin Pharmacol Ther. 2012 Jul;92(1):103-11. doi: 10.1038/clpt.2012.34. Epub 2012 May 16. Erratum in: Clin Pharmacol Ther. 2013 Jan;93(1):129. Dosage error in article text.

14.

Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.

Jablonski MR, Jacob DA, Campos C, Miller DS, Maragakis NJ, Pasinelli P, Trotti D.

Neurobiol Dis. 2012 Aug;47(2):194-200. doi: 10.1016/j.nbd.2012.03.040. Epub 2012 Apr 11.

15.

ABC transporter function and regulation at the blood-spinal cord barrier.

Campos CR, Schröter C, Wang X, Miller DS.

J Cereb Blood Flow Metab. 2012 Aug;32(8):1559-66. doi: 10.1038/jcbfm.2012.47. Epub 2012 Apr 4.

16.

Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Ronaldson PT, Davis TP.

Ther Deliv. 2011 Aug;2(8):1015-41. doi: 10.4155/tde.11.67. Review.

17.

Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS.

Wang X, Hawkins BT, Miller DS.

J Cereb Blood Flow Metab. 2011 Jun;31(6):1371-5. doi: 10.1038/jcbfm.2011.44. Epub 2011 Apr 13.

18.

Engaging neuroscience to advance translational research in brain barrier biology.

Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, Leybaert L, Molnár Z, O'Donnell ME, Povlishock JT, Saunders NR, Sharp F, Stanimirovic D, Watts RJ, Drewes LR.

Nat Rev Neurosci. 2011 Mar;12(3):169-82. doi: 10.1038/nrn2995. Review.

19.

Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.

Wang X, Hawkins BT, Miller DS.

FASEB J. 2011 Feb;25(2):644-52. doi: 10.1096/fj.10-169227. Epub 2010 Nov 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk